Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)
China · Delayed Price · Currency is CNY 26.59
+0.20 (0.76%)
Jul 31, 2026, 3:00 PM CST
SHA:688076 Market Cap
SHA:688076 has a market cap or net worth of 8.4 billion as of July 31, 2026. Its market cap has decreased by -45.16% in one year.
Market Cap
8.40B
Enterprise Value
10.19B
Revenue
1.93B
Ranking
n/a
PE Ratio
27.19
Stock Price
26.59
ChartMarket Cap Chart
Since May 20, 2021, SHA:688076's market cap has decreased from 16.52B to 8.40B, a decrease of -49.13%. That is a compound annual growth rate of -12.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 8.40B | -29.47% |
| Dec 31, 2025 | 11.92B | 4.42% |
| Dec 31, 2024 | 11.41B | 19.08% |
| Dec 29, 2023 | 9.58B | 95.95% |
| Dec 30, 2022 | 4.89B | -44.50% |
| Dec 31, 2021 | 8.81B | -46.67% |
| May 20, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanjing Vazyme Biotech | 8.82B |
| Jiangxi Fushine Pharmaceutical | 8.78B |
| Vcanbio Cell & Gene Engineering Corp., | 8.47B |
| Chengdu Olymvax Biopharmaceuticals | 8.33B |
| Sino Biological,Inc. | 8.15B |
| Liaoning Chengda Biotechnology | 8.12B |
| Chongqing Genrix Biopharmaceutical | 8.10B |
| Acrobiosystems | 7.94B |